Last reviewed · How we verify
NCT05630742: BPS/IC
Quality of Life Analysis in Bladder Pain Syndrome/Interstitial Cystitis
trial testing chronic non-neoplastic pain in Interstitial Cystitis, Bladder Pain Syndrome, Quality of Life in 69 participants. Completed in 1 September 2022.
31 July 2022
Quick facts
| Lead sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 69 |
| Start date | 1 November 2021 |
| Primary completion | 31 July 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- chronic non-neoplastic pain
Conditions studied
- Interstitial Cystitis, Bladder Pain Syndrome, Quality of Life — all drugs for Interstitial Cystitis, Bladder Pain Syndrome, Quality of Life →
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Who can join
Adults 18 to 82, female only, with Interstitial Cystitis, Bladder Pain Syndrome, Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of our study was to evaluate whether there is a higher prevalence of anxiety-depressive disorders in women with interstitial cystitis than in women with chronic non-neoplastic pain with or without fibromyalgia, to examine possible correlations between urological and psychiatric symptoms, analyze how urological symptoms affect psychological dimension, and how specific stress or trauma can contribute to the onset of interstitial cystitis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
This pain drives me crazy: Psychiatric symptoms in women with interstitial cystitis/bladder pain syndrome.
Mazza M, Margoni S, Mandracchia G, Donofrio G, et al · · 2024 · cited 6× · PMID 38984334 · DOI 10.5498/wjp.v14.i6.954
Verify or expand the search:
- PubMed search for NCT05630742
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Fondazione IRCCS Policlinico San Matteo di Pavia trials
Trials by the same sponsor.
- NCT07534007 — Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo · recruiting
- NCT07494344 — Italian Retrospective/Prospective Observational Study on Prosthetic Surgery in Patients With Congenital Coagulation Dise · recruiting
- NCT07356583 — Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on · recruiting
- NCT07435207 — Thrombotic RIsk FActors in AL-goneurodystrophy · enrolling by invitation
- NCT07263802 — Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05630742 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione IRCCS Policlinico San Matteo di Pavia
- Last refreshed: 30 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05630742.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing